News

Ozempic and Mounjaro have new competitor as trial sees people lose 20% of body weight in one year
The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...
Health and Me on MSN12h
Not Wegovy or Mounjaro Or Ozempic: This New Monthly Weight Loss Jab Helped People Drop 20% Body Fat
A new monthly weight loss drug, MariTide, helped people shed up to 20% of body weight in a Phase 2 trial—comparable to Wegovy ...
STAT1d
Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
BioPharma Dive19h
New Amgen obesity drug data disappoint Wall Street
Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...
Fierce Biotech22h
Amgen rolls out phase 3 dosing plan for lead obesity candidate after midstage trial sees high discontinuation, vomiting rates
While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...
Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update
Amgen shares are trading lower Monday afternoon. The company released full results from part one of its phase two study of ...
Pharmabiz4h
Amgen announces phase 2 obesity study results of MariTide; presents at 85th American Diabetes Association Scientific Sessions
Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...
New once-a-month drug could treat diabetes and obesity, scientists say
New once-a-month drug could treat diabetes and obesity, scientists say - Researchers say experimental drug’s less frequent ...